Measuring all the economic impacts of MS to aid resourcing

Dr Julie Campbell

Menzies Institute for Medical Research, University of Tasmania, TAS

January 2024

specialisation: Social And Applied Research

focus area: Causes and Prevention

funding type: Fellowship

project type: Investigator Led Research

Summary

This project will build on Dr Campbell’s work in MS health economics to measure the broader economic impact of MS.

Dr Campbell’s work as part of the Health Economic Impact of MS in Australia report has estimated that the cost of MS to the Australian society was $2.5 billion in 2021. As disability for the person living with MS increases from no disability to severe disability, this cost increases by almost 300%. Additionally, the numbers of people being diagnosed with MS is rapidly accelerating – 30% in the past four years.

This project aims to measure the true economic cost and to also prevent these costs of increased disability by increasing resources for MS. To do this, the project will include five connected phases of research that will:

  1. Measure the burden, costs, and quality of life for the informal carers and supporters of their person living with MS;
  2. Measure the costs and quality of life impact in the years leading up to formal diagnosis of MS – also known as the MS prodrome;
  3. Closely examine how access to the National Disability Insurance Scheme (NDIS) and the value of NDIS packages for people living with MS and their families can be improved;
  4. Create two specialised and free online courses (massive open online courses) to support carers and supporters of people living with MS, and to also provide information about the NDIS to improve knowledge and confidence for people with MS and their families and supporters;
  5. Supplement a health economics digital model that is being created by the Menzies MS Research Flagship in partnership with MS Australia. The findings of this project will help with increased resourcing for MS; and
  6. Include as much information about societal impacts as possible in clinical trials to aid increased resourcing.

Progress

Dr Campbell and her team have been working toward measuring the broader economic impacts of MS for people living with MS, their carers and supporters and the broader Australian society. These impacts will be included in their health economics model. A community of interest will be created in 2026 to make the model accessible for the MS community and researchers worldwide.

To date, Dr Campbell has found that the average cost of caring for people with MS increases dramatically as disability severity increases, but the costs were based on the perspective of the person with MS, not the carers themselves.

Over the next year, Dr Campbell will launch a specialized MOOC and gather further data about costs from carers and supporters. The specialized MOOC is for carers and supporters of people living with MS and will have three modules. The final model about self-care will help carers and supporters avoid burnout and compassion fatigue.

Dr Campbell and her team have also prepared a paper that examines existing online resources for carers and supporters for people with MS. This included podcasts, guidelines and flyers, which Dr Campbell found were often fragmented and did not focus on self-care.

Data gathering for NDIS costs is underway and will be examined closely during 2025. Costing the MS prodrome with Canadian colleagues is also underway and Dr Campbell will travel to Canada in 2026 to complete this.

publications

Henson, G. J., van der Mei, I., Taylor, B. V., Scuffham, P., Chen, G., & Campbell, J. A. (2025). A systematic review of minimum important changes for generic multi-attribute utility instruments and recommendations for their estimation. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 17 pages. doi:10.1007/s10198-025-01778-3

Last updated: 31 March 2025

lead investigator

co-investigator

Professor Andrew Palmer
Professor Ingrid van der Mei

total funding

$225,000

start year

2024

duration

3 years

STATUS

Current project

Stages of the research process

Fundamental laboratory Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline

10+ years

Translational Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline

5+ years

Clinical Studies and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline

3+ years

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Measuring all the economic impacts of MS to aid resourcing